Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “imatinib”
BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
ClinicalTrials.gov study NCT00112775. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate Imatinib in Desmoid Tumors
ClinicalTrials.gov study NCT01137916. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00302016. IPD Sharing: Not stated. Countries: 34. Publications: 1.
MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
ClinicalTrials.gov study NCT01991379. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT00171977. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Mye
ClinicalTrials.gov study NCT00055874. IPD Sharing: Not stated. Countries: 2. Publications: 11.
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
ClinicalTrials.gov study NCT00387933. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008
ClinicalTrials.gov study NCT00084825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01437202. IPD Sharing: Not stated. Countries: 2. Publications: 7.
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
ClinicalTrials.gov study NCT06061094. IPD Sharing: NO. Countries: 1. Publications: 0.
Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer
ClinicalTrials.gov study NCT00601510. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy
ClinicalTrials.gov study NCT00297570. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log
ClinicalTrials.gov study NCT03239886. IPD Sharing: NO. Countries: 1. Publications: 1.
Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
ClinicalTrials.gov study NCT01267695. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Retrospective Study of C-kit Mutation Status in Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib.
ClinicalTrials.gov study NCT01227746. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT00130195. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Dynamic Changes in the Levels of sCD62L and SPARC in Chronic Myeloid Leukemia Patients During Imatinib Treatment
ClinicalTrials.gov study NCT05387330. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Data from: A novel Imatinib analog inhibitor of chronic myeloid leukemia: design, synthesis, and characterization. Explanation of its folded conformation
Open the record for dataset details and reuse information.
Dasatinib for imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia_database INFINITY_data_export
Open the record for dataset details and reuse information.
Article data of The Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib and nilotinib Treatment in A Sample of Iraqi Chronic Myeloid Leukemia-Chronic Phase Patients
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.